Curtana Pharmaceuticals Company

Curtana is a biopharmaceutical company that has developed therapies for the treatment of the most aggressive types of brain cancer.


Investors

Last Funding Type: Grant
Funding Status: Seed
Headquarters: Austin, Texas, United States
Founded Date: 2013
Investor Type: Seed
Last Funding Date: 2017
Total Funding: 52288
Technology: Small Molecules
Employee Number: 1-10
Estimated Revenue: Less than $1M
Investors Number: 3
Industry: Biopharma, Biotechnology, Pharmaceutical